company background image
1099 logo

Sinopharm Group SEHK:1099 Rapport sur les actions

Dernier prix

HK$18.56

Capitalisation boursière

HK$57.9b

7D

-6.3%

1Y

-15.1%

Mise à jour

24 Aug, 2024

Données

Finances de l'entreprise +

Sinopharm Group Co. Ltd.

SEHK:1099 Rapport sur les actions

Capitalisation boursière : HK$57.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

1099 Aperçu des actions

Sinopharm Group Co. Ltd. et ses filiales exercent des activités de vente en gros et au détail de produits pharmaceutiques, d'appareils médicaux et de produits de santé en République populaire de Chine.

A propos de l'entreprise

1099 analyse fondamentale
Score flocon de neige
Évaluation6/6
Croissance future2/6
Performances passées4/6
Santé financière6/6
Dividendes5/6

Récompenses

Se négocie à 50.5% en dessous de notre estimation de sa juste valeur
Les bénéfices devraient augmenter 6.69% par an
Les revenus ont augmenté 9% par an au cours des 5 dernières années
Verse un dividende fiable de 4.87%
Se négocie à un bon prix par rapport à ses pairs et au secteur
Les analystes s'accordent à dire que le prix des actions augmentera de 35.8%

Analyse des risques

Aucun risque n'a été détecté pour 1099 à partir de nos contrôles de risques.

Sinopharm Group Co. Ltd. Concurrents

Guangzhou Baiyunshan Pharmaceutical Holdings

SEHK:874

HK$49.0b

Shanghai Pioneer Holding

SEHK:1345

HK$2.4b

Tycoon Group Holdings

SEHK:3390

HK$3.0b

IVD Medical Holding

SEHK:1931

HK$1.1b

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Sinopharm Group
Historique des cours de bourse
Prix actuel de l'actionHK$18.56
Plus haut sur 52 semainesHK$23.20
Plus bas sur 52 semainesHK$17.44
Bêta0.86
1Variation sur 1 mois0.98%
Variation sur 3 mois-12.86%
Variation sur 1 an-15.06%
3Variation sur 3 ans-2.21%
Variation sur 5 ans-34.53%
Évolution depuis l'introduction en bourse0.22%

Nouvelles et mises à jour récentes

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Aug 23
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Jul 27
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Recent updates

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Aug 23
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Jul 27
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Apr 22
Is Sinopharm Group (HKG:1099) A Risky Investment?

Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Mar 21
Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Mar 06
Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Jan 31
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Jan 15
Is Sinopharm Group (HKG:1099) A Risky Investment?

There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Dec 31
There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

Nov 29
Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Nov 14
If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Nov 01
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Sep 20
Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sep 05
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Aug 18
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Aug 02
Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Jun 01
Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Apr 26
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Feb 27
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jul 31
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Jul 10
Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

Jun 05
Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Apr 11
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Mar 21
A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Mar 03
Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jan 09
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Dec 19
Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Dec 01
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sep 23
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Sep 10
A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Aug 28
Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Jun 13
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Jun 06
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

May 24
Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

May 11
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

Mar 20
Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

Mar 05
We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Feb 18
You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Feb 03
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

Jan 19
Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

Jan 06
At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Dec 25
What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Rendement pour les actionnaires

1099HK HealthcareHK Marché
7D-6.3%-4.3%0.3%
1Y-15.1%-29.9%4.0%

Rendement vs Industrie: 1099 a dépassé le secteur Hong Kong Healthcare qui a rapporté -30.6 % au cours de l'année écoulée.

Rendement vs marché: 1099 a sous-performé le marché Hong Kong qui a rapporté 6.2 % au cours de l'année écoulée.

Volatilité des prix

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.1%
Healthcare Industry Average Movement5.6%
Market Average Movement6.3%
10% most volatile stocks in HK Market13.1%
10% least volatile stocks in HK Market3.3%

Cours de l'action stable: 1099 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de 1099 ( 4% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
2003115,959Yong Liuwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd. et ses filiales se consacrent à la vente en gros et au détail de produits pharmaceutiques, de dispositifs médicaux et de produits de santé en République populaire de Chine. L'entreprise opère à travers quatre segments : Distribution pharmaceutique, Dispositifs médicaux, Pharmacie de détail et Autres activités. Le secteur de la distribution pharmaceutique distribue des produits pharmaceutiques aux hôpitaux, aux autres distributeurs, aux pharmacies de détail et aux cliniques.

Sinopharm Group Co. Ltd. Résumé des fondamentaux

Comment les bénéfices et les revenus de Sinopharm Group se comparent-ils à sa capitalisation boursière ?
1099 statistiques fondamentales
Capitalisation boursièreHK$57.92b
Bénéfices(TTM)HK$9.92b
Recettes(TTM)HK$653.45b

5.8x

Ratio P/E

0.1x

Ratio P/S

Le site 1099 est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
1099 compte de résultat (TTM)
RecettesCN¥597.19b
Coût des recettesCN¥548.79b
Marge bruteCN¥48.40b
Autres dépensesCN¥39.33b
Les revenusCN¥9.07b

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)2.91
Marge brute8.10%
Marge bénéficiaire nette1.52%
Ratio dettes/capitaux propres1.3%

Quelles ont été les performances à long terme de 1099?

Voir les performances historiques et les comparaisons

Dividendes

5.2%

Rendement actuel des dividendes

30%

Ratio de distribution